Halothane and other halogenated inhalational anesthetic agents, such as enflurane, isoflurane, sevoflurane, and desflurane, are known to cause severe liver dysfunction. The National Halothane Study, a retrospective analysis, reviewed the incidence and mortality rates of postoperative hepatic necrosis … See more Type I (mild) halothane hepatotoxicity occurs within hours of halothane exposure. It does not occur after other agents. Type I is characterized by mild, transient elevations … See more Also see Treatment. No specific therapy is available for either fulminant hepatic necrosis or mild hepatotoxicity due to halothane. Only supportive therapy and orthotopic liver transplantation are available for hepatic … See more A CBC count with differential may show mild leukocytosis or eosinophilia. The bilirubin level may be more than 170 μg/L. Serum transaminase levels are elevated. An enzyme-linked … See more
Halothane induced hepatitis - SlideShare
WebJul 8, 2024 · Halothane and other halogenated inhalational anesthetic agents, such as enflurane, isoflurane, sevoflurane, and desflurane, are known to cause severe liver … WebHalothane (also known as 2-bromo-2-chloro-1,1,1-trifluoroethane), sold under the brand name Fluothane among others, is a general anaesthetic. It can be used to induce or … frohnleiten iranyitoszam
Halothane Hepatotoxicity - Medscape
WebLymphocytes from 11 patients with halothane hepatitis showed an increase in cytotoxicity that was 8 times greater than the increase in normal controls, patients with other forms of liver disease and persons exposed to halothane without adverse effects. In the 3 patients studied, the lymphocyte abnormality was still present 13 months after first ... WebHalothane-related hepatitis can result from use of anesthetics containing halothane or related agents. It usually develops within 2 weeks, is often preceded by fever, and is … WebOnce halothane hepatitis has developed, there are no specific treatments and liver replacement may be required. Halothane hepatitis is a paradigm for immune mediated adverse drug reactions. The mechanism appears to be related to development of sensitization to both autoantigens (including CYP2D6) and halothane-altered liver cell … froilyn mendoza